Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Unfolding of in planta activity of anti-rep ribozyme in presence of a RNA silencing suppressor.

FEBS letters·2014
Same author

Taylor cows of Patna.

The Indian veterinary journal·2014
Same author

Studies on melothria maderasapatana (linn). Cogn.

Ancient science of life·2012
Same author

Biochemical and hematological evaluations of bryonia epigaea tubers.

Ancient science of life·2012
Same author

Phenomenology of mania - a factor analysis approach.

Indian journal of psychiatry·2011
Same author

Gender difference in resolution of mania.

Indian journal of psychiatry·2011
Same journal

Anemia associated with long-acting injectable aripiprazole in an elderly man.

Indian journal of psychiatry·2026
Same journal

Psychiatric comorbidities and treatment patterns in epilepsy: A retrospective review from a tertiary neuropsychiatric clinic.

Indian journal of psychiatry·2026
Same journal

Proposal of 'World Psychiatry Day': The aim is to celebrate psychiatry as the third division of medicine alongside internal medicine and general surgery.

Indian journal of psychiatry·2026
Same journal

A bibliometric assessment of the <i>Indian Journal of Psychiatry</i>: Trends, impact, and collaboration (2009-2024).

Indian journal of psychiatry·2026
Same journal

Narcotic bowel syndrome misdiagnosed as somatoform pain disorder and presenting with opioid use disorder - A case report.

Indian journal of psychiatry·2026
Same journal

From tramadol to pregabalin addiction: A case report of unsupervised substance substitution and temporally improved in craving with fluoxetine.

Indian journal of psychiatry·2026
See all related articles

Related Experiment Video

Updated: Jun 3, 2026

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

Lithium toxicity - a descriptive study.

R Kumar1, J K Deb, B N Sinha

  • 1RATANENDRA KUMAR, B.Sc., MBBS, MD(Psych), DPM, Consultant Psychiatrist, Chikitsayan Treatment Centre.

Indian Journal of Psychiatry
|March 17, 2011
PubMed
Summary
This summary is machine-generated.

Lithium toxicity, a known risk in treating bipolar disorder, often presents with cerebellar symptoms even at lower serum levels. In many cases, lithium can be safely restarted at a lower dose with careful titration.

Keywords:
Lithiumcerebellarrechallengetherapeutictoxicity

More Related Videos

Failure Analysis of Batteries Using Synchrotron-based Hard X-ray Microtomography
08:11

Failure Analysis of Batteries Using Synchrotron-based Hard X-ray Microtomography

Published on: August 26, 2015

Related Experiment Videos

Last Updated: Jun 3, 2026

The Tail Suspension Test
10:17

The Tail Suspension Test

Published on: January 28, 2012

Failure Analysis of Batteries Using Synchrotron-based Hard X-ray Microtomography
08:11

Failure Analysis of Batteries Using Synchrotron-based Hard X-ray Microtomography

Published on: August 26, 2015

Area of Science:

  • Psychiatry
  • Clinical Pharmacology
  • Neuroscience

Background:

  • Lithium is a primary treatment for acute mania and bipolar disorders.
  • Despite its efficacy, lithium toxicity is a recurring concern, with case reports documented since its introduction.
  • Understanding the presentation and features of lithium toxicity is crucial for patient safety.

Purpose of the Study:

  • To investigate the clinical presentation and associated features of lithium toxicity.
  • To identify patterns and characteristics of lithium toxicity in patients.

Main Methods:

  • A retrospective study design was employed.
  • Case record files of patients with suspected lithium toxicity over a five-year period were reviewed.

Main Results:

  • Lithium toxicity most commonly manifested with cerebellar symptoms.
  • Toxicity was observed to occur at lower serum lithium levels than previously suggested.
  • A significant number of patients could tolerate the reintroduction of lithium at a reduced dosage with gradual titration.

Conclusions:

  • Cerebellar symptoms are a key indicator of lithium toxicity, often appearing at lower serum concentrations.
  • Careful dose adjustment and gradual titration allow for the safe re-administration of lithium in many patients experiencing toxicity.
  • This highlights the importance of vigilant monitoring and individualized treatment adjustments in lithium therapy.